Xc. Luo et al., LIGAND-INDUCED DOMAIN MOTION IN THE ACTIVATION MECHANISM OF A G-PROTEIN-COUPLED RECEPTOR, Protein engineering, 7(12), 1994, pp. 1441-1448
Rapidly accumulating information about the structures and functions of
transmembrane proteins in the class of G-protein-coupled receptors is
facilitating the exploration of molecular details in the processes of
cellular signal transduction. We have described recently a 3-D molecu
lar model of the transmembrane portion of the 5-HT2A type of receptor
of the neurotransmitter serotonin (5-hydroxy-tryptamine; 5-HT), constr
ucted from such convergent empirical and theoretical considerations, a
nd have used it for a computational simulation of the mechanisms of li
gand-induced receptor activation and signal transduction. The molecula
r dynamics (MD) simulation of the interaction between the receptor mod
el and ligands of different pharmacological efficacies pointed to a se
t of specific conformational changes propagated from the ligand bindin
g site to a distal region of the receptor that is essential for signal
transduction. The ligand-induced changes were found to correlate well
. with the known pharmacological properties, but it remained unclear h
ow the binding of the small 5-HT2A receptor agonist molecules in the d
istal binding pocket could give rise to the specific conformational ch
anges in a distant part of the receptor. As the MD simulations showed
the secondary structure of the helical transmembrane domains of the re
ceptor to be well maintained, and the conformational changes to involv
e mainly translations and rotations of the helices in the bundle relat
ive to one another, an algorithm was developed to treat the ligand-ind
uced conformational changes as rigid domain movements of transmembrane
helices. The application of this algorithm to the analysis of MD traj
ectories for ligand-receptor complexes revealed a series of torques an
d inter-helix interaction forces that trigger the rotations responsibl
e for domain motions. The detailed analysis explains the differences i
n the effects of pharmacologically distinct ligands observed from the
MD simulations, and offers structural inferences that are verifiable w
ith mutation experiments designed to diminish or enhance specific heli
x-ligand or helix-helix interactions.